Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
27
HAO Quote, Financials, Valuation and Earnings
Last price:
$1.04
Seasonality move
:
-65.55%
Day range:
$1.01 - $1.05
52-week range:
$0.82 - $4.99
Dividend yield:
0%
P/E ratio:
0.76x
P/S ratio:
0.09x
P/B ratio:
0.17x
Volume:
9.9K
Avg. volume:
22.2K
1-year change:
-62.56%
Market cap:
$2.9M
Revenue:
$32.8M
EPS (TTM):
$0.04
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Haoxi Health Technology Ltd. has -- downside to fair value with a price target of -- per share.
HAO vs. S&P 500
-
Over the past 5 trading days, Haoxi Health Technology Ltd. has underperformed the S&P 500 by -3.26% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Haoxi Health Technology Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Haoxi Health Technology Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Haoxi Health Technology Ltd. reported revenues of --.
Earnings Growth
-
Haoxi Health Technology Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Haoxi Health Technology Ltd. reported earnings per share of --.
Enterprise value:
-4.7M
EV / Invested capital:
--
Price / LTM sales:
0.09x
EV / EBIT:
-4.89x
EV / Revenue:
-0.10x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
0.88x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
-4.84x
Gross Profit (TTM):
$2.8M
Return On Assets:
14.82%
Net Income Margin (TTM):
2.66%
Return On Equity:
26.61%
Return On Invested Capital:
22.15%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $16.2M | $28.2M | $48.5M | -- | -- | |
| Gross Profit | -- | -- | $2.8M | -- | -- | |
| Operating Income | $268.8K | $1.2M | $1.7M | -- | -- | |
| EBITDA | $271.8K | $1.2M | $1.7M | -- | -- | |
| Diluted EPS | -- | -- | $0.95 | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $445.1K | $3.7M | $15.4M | -- | |
| Total Assets | -- | $543K | $4.5M | $15.5M | -- | |
| Current Liabilities | -- | $2M | $2.6M | $3.9M | -- | |
| Total Liabilities | -- | $2M | $2.9M | $4.2M | -- | |
| Total Equity | -- | -$1.5M | $1.6M | $11.3M | -- | |
| Total Debt | -- | $439.4K | $760.5K | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-25 | 2024-12-25 | 2024-12-25 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
HAO
Sector
Market Cap
$2.9M
$51M
Price % of 52-Week High
20.36%
62.77%
Dividend Yield
0%
0%
Shareholder Yield
--
1.13%
1-Year Price Total Return
-62.56%
-5.42%
Beta (5-Year)
--
0.326
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.02
200-day SMA
Sell
Level
$1.25
Bollinger Bands (100)
Sell
Level
1 - 1.26
Chaikin Money Flow
Sell
Level
-22.7M
20-day SMA
Sell
Level
$1.02
Relative Strength Index (RSI14)
Buy
Level
50.05
ADX Line
Buy
Level
11.52
Williams %R
Neutral
Level
-49.738
50-day SMA
Sell
Level
$1.03
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
31.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.907)
Buy
CA Score
(Annual)
Level (0.9936)
Sell
Beneish M-Score
(Annual)
Level (13.4462)
Sell
Momentum Score
Level (1)
Buy
Ohlson Score
Level (-3.448)
Buy
Piotroski F Score
(Annual)
Level (5)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Haoxi Health Technology Ltd. is a holding company, which engages in the provision of online marketing solutions. It produces online ads for advertisers to acquire, convert, and retain consumers on various media platforms. The company was founded on September 26, 2018 and is headquartered in Beijing, China.
Stock Forecast FAQ
In the current month, HAO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HAO average analyst price target in the past 3 months is --.
-
Where Will Haoxi Health Technology Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Haoxi Health Technology Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Haoxi Health Technology Ltd.?
Analysts are divided on their view about Haoxi Health Technology Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Haoxi Health Technology Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is Haoxi Health Technology Ltd.'s Price Target?
The price target for Haoxi Health Technology Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HAO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Haoxi Health Technology Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HAO?
You can purchase shares of Haoxi Health Technology Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Haoxi Health Technology Ltd. shares.
-
What Is The Haoxi Health Technology Ltd. Share Price Today?
Haoxi Health Technology Ltd. was last trading at $1.04 per share. This represents the most recent stock quote for Haoxi Health Technology Ltd.. Yesterday, Haoxi Health Technology Ltd. closed at $1.02 per share.
-
How To Buy Haoxi Health Technology Ltd. Stock Online?
In order to purchase Haoxi Health Technology Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get HAO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HAO
Sector
P/E ratio
0.76x
16.33x
PEG ratio
0.01x
0.00x
P/B ratio
0.17x
1.30x
Price / LTM sales
0.09x
0.85x
Growth Metrics
HAO
Sector
Revenue growth
--
1.07%
Earnings growth
--
9.34%
Revenue (5-year growth)
--
1.1%
Earnings forecast
--
$0.05
Profitability
HAO
Sector
Profitability FY 2025
$927.8K
$109.7M
Return on invested capital
22.15%
0.48%
Return on assets
14.82%
-0.17%
Return on equity
26.61%
1.42%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Dec
25
Estimated Next Earnings Date
Mar
26
Balance Sheet
HAO
Sector
Total cash
$6.7M
$72.3M
Short term investments
--
$24.7M
Total assets
$21.6M
$549.2M
Long term debt
$1.2M
$12.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
